Eurofins Optimed

Gieres 15 trials 1 recruiting

15 Registered trials

1 Currently recruiting

Organisation

Eurofins Optimed

Location

Gieres, France

Identifier

ORG-100009070

Address

1 Rue Des Essarts, 38610, France

Departments

Clinical Unit
Clinical pharmacology unit
Clinical Research
Clinical unit
EUROFINS OPTIMED
Not applicable

Clinical trials at this site (15)

Search interface

Etude de bioéquivalence entre Circadin et Melatonin PILEJE LP 2 mg Pending

2024-519932-17-00 Primary insomnia characterized by poor quality of sleep 2
A phase 1, Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt (EYP651) and Evaluation of Potential Drug-Drug Interactions. Recruiting

2025-522915-40-00 Healthy volunteers, Impaired renal function and suspect 3 2025-10-28
Bioavailability study of stiripentol after single oral administration of two different formulations (capsule and oral suspension) in 24 heal… Ended

2024-520103-38-00 Dravet syndrome 3 2025-05-26
A Phase 1, Randomized, Double-Blind, Placebo-Controlled study to Evaluate the Safety, Tolerability,and Pharmacokinetics of Single and Multi… Ended

2024-515549-40-00 neurological disease 1 2025-02-21
A Phase 1, randomized, double blind, single center, placebo controlled, single escalating weight-adjusted dose, safety study of HI-6 dimethy… Ended

2023-509020-17-00 Treatment of patients poisoned with organophosphorus co 1 2024-11-25
First administration of a single and increasing doses of BDT272 to assess its safety and pharmacokinetic in healthy volunteers Ended

2024-515415-22-00 Moderate to severe pain 1 2024-11-25
Evaluation of safety and pharmacokinetic parameters of the PTI5803 product Ended

2024-512472-35-00 Epilepsy 3 2024-07-23
A Phase 1, 2-part, open-label, single-sequence study to investigate the effect of single and multiple doses of obefazimod on the pharmacokin… Ended

2023-509226-21-00 Moderately to severely active ulcerative colitis 3 2024-06-13
Exploratory study to assess the pharmacokinetic interaction of doxepin with adrenaline after a concomitant co-administration using the Anape… Ended

2023-508117-16-00 Anaphylaxis 3 2024-05-03
A phase 1, open-label, cross-over study in healthy volunteers to assess the pharmacokinetic profile of Prazosin and Cyproheptadine following… Ended

2023-507788-20-00 alcohol use disorder 1 2024-04-11
Testing for the first time the effects of a new medicine in healthy people Ended

2023-507880-20-00 Psychatric disorder 1 2024-02-05
[HIBOU] : A phase I, single-center, randomized, double-blind, single-dose escalation, placebo-controlled clinical study to evaluate the safe… Ended

2023-509035-30-00 Antidote 1 2024-01-18
A study to evaluate the safety, tolerance and changes in blood levels of an anti-toxin drug (FBT-002) in healthy male and female subjects Ended

2023-505745-16-00 Antidote 1 2024-01-05
Safety, pharmacokinetics and pharmacodynamics study of Leucettinib-21 in healthy subjects, Down Syndrom and Alzheimer patients Ended

2023-507075-22-00 A Phase 1, Randomized, Double-Blind, Placebo-Controlled 1 2024-01-05
A study to find out how healthy people tolerate a new drug called S221237. Ended

2024-519381-53-00 Parkinson disease (PD) 1 2022-10-04